APA

Lattanzi S. C., Tosteson T., Chertoff J., Maurer L. H., O'Donnell J., LeMarbre P. J., Mott L., DelPrete S. A., Forcier R. J. & Ernstoff M. S. (19960213). Dacarbazine, cisplatin and carmustine, with or without tamoxifen, for metastatic melanoma: 5-year follow-up. : Melanoma research.

Chicago

Lattanzi S C, Tosteson T, Chertoff J, Maurer L H, O'Donnell J, LeMarbre P J, Mott L, DelPrete S A, Forcier R J and Ernstoff M S. 19960213. Dacarbazine, cisplatin and carmustine, with or without tamoxifen, for metastatic melanoma: 5-year follow-up. : Melanoma research.

Harvard

Lattanzi S. C., Tosteson T., Chertoff J., Maurer L. H., O'Donnell J., LeMarbre P. J., Mott L., DelPrete S. A., Forcier R. J. and Ernstoff M. S. (19960213). Dacarbazine, cisplatin and carmustine, with or without tamoxifen, for metastatic melanoma: 5-year follow-up. : Melanoma research.

MLA

Lattanzi S C, Tosteson T, Chertoff J, Maurer L H, O'Donnell J, LeMarbre P J, Mott L, DelPrete S A, Forcier R J and Ernstoff M S. Dacarbazine, cisplatin and carmustine, with or without tamoxifen, for metastatic melanoma: 5-year follow-up. : Melanoma research. 19960213.